Latest Insider Transactions at Trans Union (TRU)
This section provides a real-time view of insider transactions for Trans Union (TRU). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of TransUnion to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of TransUnion's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 17
2017
|
David M Neenan President, International |
SELL
Open market or private sale
|
Indirect |
12,314
-6.46%
|
$467,932
$38.2 P/Share
|
Mar 22
2017
|
Sumit Rajpal |
SELL
Open market or private sale
|
Indirect |
992,500
-2.17%
|
$35,730,000
$36.57 P/Share
|
Mar 22
2017
|
Goldman Sachs Group Inc |
SELL
Open market or private sale
|
Indirect |
992,500
-2.17%
|
$35,730,000
$36.57 P/Share
|
Mar 22
2017
|
Gscp Vi Advisors, L.L.C. |
SELL
Open market or private sale
|
Indirect |
992,500
-2.17%
|
$35,730,000
$36.57 P/Share
|
Mar 22
2017
|
Steven M Tadler Director |
SELL
Open market or private sale
|
Indirect |
16,079
-3.58%
|
$578,844
$36.57 P/Share
|
Mar 22
2017
|
Christopher Egan Director |
SELL
Open market or private sale
|
Indirect |
16,674
-3.58%
|
$600,264
$36.57 P/Share
|
Mar 22
2017
|
Advent International Corp > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,985,000
-3.58%
|
$71,460,000
$36.57 P/Share
|
Mar 15
2017
|
Samuel A Hamood |
SELL
Open market or private sale
|
Indirect |
185,749
-47.55%
|
$6,872,713
$37.58 P/Share
|
Mar 15
2017
|
Samuel A Hamood |
BUY
Exercise of conversion of derivative security
|
Indirect |
350,801
+47.31%
|
$1,403,204
$4.99 P/Share
|
Mar 14
2017
|
Sumit Rajpal |
BUY
Open market or private purchase
|
Indirect |
1,057
+0.0%
|
$39,109
$37.72 P/Share
|
Mar 14
2017
|
Gscp Vi Advisors, L.L.C. |
BUY
Open market or private purchase
|
Indirect |
1,057
+0.0%
|
$39,109
$37.72 P/Share
|
Mar 14
2017
|
Goldman Sachs Group Inc |
BUY
Open market or private purchase
|
Indirect |
1,057
+0.0%
|
$39,109
$37.72 P/Share
|
Feb 22
2017
|
Sumit Rajpal |
SELL
Open market or private sale
|
Indirect |
9,730,500
-17.53%
|
$350,298,000
$36.57 P/Share
|
Feb 22
2017
|
Goldman Sachs Group Inc |
SELL
Open market or private sale
|
Indirect |
9,730,500
-17.53%
|
$350,298,000
$36.57 P/Share
|
Feb 22
2017
|
Gscp Vi Advisors, L.L.C. |
SELL
Open market or private sale
|
Indirect |
9,730,500
-17.53%
|
$350,298,000
$36.57 P/Share
|
Feb 22
2017
|
David M Neenan President, International |
SELL
Open market or private sale
|
Indirect |
90,000
-17.37%
|
$3,240,000
$36.78 P/Share
|
Feb 22
2017
|
Christopher Egan Director |
SELL
Open market or private sale
|
Indirect |
163,472
-25.98%
|
$5,884,992
$36.57 P/Share
|
Feb 22
2017
|
Steven M Tadler Director |
SELL
Open market or private sale
|
Indirect |
157,634
-25.98%
|
$5,674,824
$36.57 P/Share
|
Feb 22
2017
|
Advent International Corp > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,461,000
-25.98%
|
$700,596,000
$36.57 P/Share
|
Feb 22
2017
|
George M Awad Director |
SELL
Open market or private sale
|
Direct |
28,000
-58.16%
|
$1,008,000
$36.57 P/Share
|
Feb 22
2017
|
Siddharth N Mehta Director |
SELL
Open market or private sale
|
Direct |
150,000
-37.3%
|
$5,400,000
$36.57 P/Share
|
Feb 22
2017
|
John T Danaher President, Consumer Inter |
SELL
Open market or private sale
|
Direct |
10,000
-21.16%
|
$360,000
$36.57 P/Share
|
Feb 22
2017
|
Gerald M Mc Carthy Jr EVP - Healthcare |
SELL
Open market or private sale
|
Direct |
11,000
-27.46%
|
$396,000
$36.57 P/Share
|
Feb 22
2017
|
James M Peck Director |
BUY
Exercise of conversion of derivative security
|
Direct |
17,428
+6.94%
|
$69,712
$4.99 P/Share
|
Feb 22
2017
|
James M Peck Director |
SELL
Open market or private sale
|
Indirect |
65,000
-12.15%
|
$2,340,000
$36.57 P/Share
|
Feb 22
2017
|
Samuel A Hamood |
SELL
Open market or private sale
|
Indirect |
60,000
-60.1%
|
$2,160,000
$36.57 P/Share
|
Feb 21
2017
|
James M Peck Director |
SELL
Open market or private sale
|
Direct |
53,514
-10.94%
|
$1,980,018
$37.07 P/Share
|
Feb 21
2017
|
James M Peck Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,731
+7.72%
|
$78,924
$4.99 P/Share
|
Feb 21
2017
|
Samuel A Hamood |
SELL
Open market or private sale
|
Indirect |
10,859
-9.81%
|
$390,924
$36.88 P/Share
|
Feb 21
2017
|
Samuel A Hamood |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,859
+8.93%
|
$43,436
$4.99 P/Share
|
Feb 17
2017
|
John W Blenke EVP, Corp GC & Asst Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
10,796
+6.94%
|
-
|
Feb 17
2017
|
Christopher A Cartwright President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
16,195
+6.93%
|
-
|
Feb 17
2017
|
Samuel A Hamood |
BUY
Grant, award, or other acquisition
|
Direct |
20,243
+50.0%
|
-
|
Feb 17
2017
|
Gerald M Mc Carthy Jr EVP - Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
9,447
+19.08%
|
-
|
Feb 17
2017
|
David M Neenan President, International |
BUY
Grant, award, or other acquisition
|
Direct |
16,195
+16.76%
|
-
|
Feb 17
2017
|
James M Peck Director |
BUY
Grant, award, or other acquisition
|
Direct |
66,802
+21.09%
|
-
|
Feb 17
2017
|
John T Danaher President, Consumer Inter |
BUY
Grant, award, or other acquisition
|
Direct |
13,496
+22.21%
|
-
|
Feb 17
2017
|
Timothy Elberfeld SVP and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
946
+6.38%
|
-
|
Dec 30
2016
|
John W Blenke EVP, Corp GC & Asst Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
20,242
-13.13%
|
$607,260
$30.93 P/Share
|
Nov 15
2016
|
James M Peck Director |
BUY
Exercise of conversion of derivative security
|
Direct |
35,886
+10.82%
|
$143,544
$4.99 P/Share
|
Nov 14
2016
|
John W Blenke EVP, Corp GC & Asst Secretary |
SELL
Open market or private sale
|
Direct |
6,000
-3.75%
|
$174,000
$29.67 P/Share
|
Nov 14
2016
|
John T Danaher President, Consumer Inter |
SELL
Open market or private sale
|
Direct |
3,334
-8.99%
|
$96,686
$29.66 P/Share
|
Nov 14
2016
|
Samuel A Hamood |
SELL
Open market or private sale
|
Indirect |
25,228
-20.2%
|
$731,612
$29.66 P/Share
|
Nov 14
2016
|
David M Neenan President, International |
SELL
Open market or private sale
|
Direct |
38,764
-10.1%
|
$1,124,156
$29.67 P/Share
|
Nov 14
2016
|
James M Peck Director |
SELL
Open market or private sale
|
Direct |
93,448
-26.46%
|
$2,709,992
$29.65 P/Share
|
Nov 14
2016
|
James M Peck Director |
BUY
Exercise of conversion of derivative security
|
Direct |
93,448
+20.92%
|
$373,792
$4.99 P/Share
|
Oct 28
2016
|
David M Neenan President, International |
BUY
Exercise of conversion of derivative security
|
Direct |
41,112
+9.68%
|
$164,448
$4.99 P/Share
|
Sep 14
2016
|
Advent International Corp > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
15,812,000
-17.43%
|
$505,984,000
$32.82 P/Share
|
Sep 14
2016
|
Christopher Egan Director |
SELL
Open market or private sale
|
Indirect |
132,821
-17.43%
|
$4,250,272
$32.82 P/Share
|
Sep 14
2016
|
Steven M Tadler Director |
SELL
Open market or private sale
|
Indirect |
128,077
-17.43%
|
$4,098,464
$32.82 P/Share
|